Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × Spinal Cord Stimulation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Glioblastoma 1 Chronic Pain 1 Chemotherapy-Induced Peripheral Neuropathy 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 142 Radiosurgery 115 Radiotherapy 95 Bevacizumab 88 Magnetic Resonance Spectroscopy 69 Carboplatin 46 Etoposide 32 pembrolizumab 31 Surgical Procedures, Operative 30 Irinotecan 30 Cyclophosphamide 30 Radiation 29 Nivolumab 29 Erlotinib Hydrochloride 28 Carmustine 25 Lomustine 24 Trastuzumab 21 Ipilimumab 21 Filgrastim 21 Cisplatin 21 Aminolevulinic Acid 21 Mental Status and Dementia Tests 19 Magnetic Resonance Imaging 19 Vincristine 18 Surveys and Questionnaires 18 Specimen Handling 17 Capecitabine 17 Topotecan 16 Pemetrexed 16 Lapatinib 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01868906 2018-08-24

FMISOPETSCS

Dr. Negrin University Hospital

Phase 2 Terminated

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡